Effects of onopordia, a novel isolated compound from Onopordon acanthium, on pentylenetetrazole-induced seizures in mice: Possible involvement of nitric oxide pathway

Abstract

Epilepsy is identified as a brain disorder and characterized by unpredictable disruption of normal brain function. Due to adverse side effect associated with antiepileptic drugs and also resistance profile, improvement of antiepileptic medications with more beneficial anticonvulsant activity is essential. Natural products have demonstrated their therapeutic properties such as anxiolytic, antidepressant and anticonvulsant activities and a source for identification of novel lead compounds. Therefore, the purpose of this study was to evaluate the effects of Onopordon acanthium secondary metabolite, onopordia, on pentylenetetrazole (PTZ)-induced seizure in male mice and investigate the possible role of nitric oxide pathway. Different doses of onopordia (0.1, 1 and 10 mg/kg) and phenobarbital (20 mg/kg) were administered intraperitoneally (i.p., 30, 60 and 120 min) prior to induction of epileptic seizure and compared to control groups. Onopordia demonstrated anticonvulsant effects when administrated at dose of 10 mg/kg, i.p. and optimum time 60 min prior to induction of seizure. Anticonvulsant effect of onopordia was blocked by applying a single dose of a non-selective nitric oxide synthase (NOS) inhibitor, Nω-nitro- l -arginine methyl ester hydrochloride ( l -NAME; 10 mg/kg, i.p.), and also a single dose of a selective neuronal NOS (nNOS) inhibitor, 7-nitroindazole (7-NI; 30 mg/kg, i.p.). Administration of ketamine as a N-Methyl- d -aspartic acid (NMDA) receptor antagonist (0.5 mg/kg; i.p.) with onopordia did not change the anticonvulsant effect of onopordia. The results of the present study demonstrated the anticonvulsant effect of onopordia as a new lead compound and also contribution of NO/nNOS pathway on PTZ-induced seizure in mice.

Medicinal plants with anticonvulsant activities with emphasis on their mechanisms of action

“…Administration of ketamine as an N-Methyl-D-aspartic acid receptor antagonist (0.5 mg/kg; ip) with onopordia did not change the anticonvulsant effect of onopordia. The results indicated that the antiepileptic effect of onopordia was attributed to NO/nNOS pathway on PTZ-induced seizure in mice [95].…”

Thioacetamide Induced in Albino Wistar Rats: Importance of Coleus aromaticus Aqueous Leaf Extract for Hepatoprotective Activity

“…Administration of ketamine as a N-Methyl-D-aspartic acid receptor antagonist with onopordia did not change the anticonvulsant effect of onopordia. 33 Plasma is proof the biochemical parameters (AST, ALT, APT, bilirubin and cholesterol) and histopathological analysis. However, the mechanism of oxidative pressure in TAA hepatotoxicity is still not clear.…”